Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Kate Lapane and Anne Hume.

 
Connection Strength
 
 
 
3.473
 
  1. Hume AL, Quilliam BJ, Goldman R, Eaton C, Lapane KL. Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf. 2011 Oct; 20(10):875-84.
    View in: PubMed
    Score: 0.569
  2. Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016. J Am Heart Assoc. 2019 May 07; 8(9):e012023.
    View in: PubMed
    Score: 0.245
  3. Liu SH, Hunnicutt JN, Ulbricht CM, Dubé CE, Hume AL, Lapane KL. Adjuvant Use and the Intensification of Pharmacologic Management for Pain in Nursing Home Residents with Cancer: Data from a US National Database. Drugs Aging. 2019 Mar 28.
    View in: PubMed
    Score: 0.243
  4. Ulbricht CM, Hunnicutt JN, Gambassi G, Hume AL, Lapane KL. Non-malignant pain symptom subgroups in nursing home residents. J Pain Symptom Manage. 2018 Nov 30.
    View in: PubMed
    Score: 0.238
  5. Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 Nov 13.
    View in: PubMed
    Score: 0.237
  6. Hunnicutt JN, Hume AL, Liu SH, Ulbricht CM, Tjia J, Lapane KL. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes. Drugs Aging. 2018 Sep 06.
    View in: PubMed
    Score: 0.234
  7. Hunnicutt JN, Baek J, Alcusky M, Hume AL, Liu SH, Ulbricht CM, Tjia J, Lapane KL. Geographic Variation in the Initiation of Commonly Used Opioids and Dosage Strength in United States Nursing Homes. Med Care. 2018 Aug 14.
    View in: PubMed
    Score: 0.233
  8. Hunnicutt JN, Hume AL, Ulbricht CM, Tjia J, Lapane KL. Long-acting opioid initiation in US nursing homes. Pharmacoepidemiol Drug Saf. 2018 Jun 04.
    View in: PubMed
    Score: 0.230
  9. Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Who are they? Patients with heart failure in American skilled nursing facilities. J Cardiol. 2018 Apr; 71(4):428-434.
    View in: PubMed
    Score: 0.220
  10. Hunnicutt JN, Chrysanthopoulou SA, Ulbricht CM, Hume AL, Tjia J, Lapane KL. Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home Residents. J Am Geriatr Soc. 2018 Jan; 66(1):48-55.
    View in: PubMed
    Score: 0.219
  11. Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay. J Card Fail. 2017 Dec; 23(12):843-851.
    View in: PubMed
    Score: 0.219
  12. Pimentel CB, Gurwitz JH, Tjia J, Hume AL, Lapane KL. New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents. J Am Geriatr Soc. 2016 Sep; 64(9):1772-8.
    View in: PubMed
    Score: 0.202
  13. Lapane KL, Goldman RE, Quilliam BJ, Hume AL, Eaton CB. Tailored DVDs: a novel strategy for educating racially and ethnically diverse older adults about their medicines. Int J Med Inform. 2012 Dec; 81(12):852-60.
    View in: PubMed
    Score: 0.156
  14. Eaton CB, Lapane KL, Murphy JB, Hume AL. Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc. 2002 Aug; 50(8):1389-95.
    View in: PubMed
    Score: 0.077
  15. Lapane KL, Hume AL, Barbour MM, Lipsitz LA. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure? J Am Geriatr Soc. 2002 Jul; 50(7):1198-204.
    View in: PubMed
    Score: 0.076
  16. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst. 2008 Sep 3; 100(17):1223-32.
    View in: PubMed
    Score: 0.029
  17. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):227-38.
    View in: PubMed
    Score: 0.023
  18. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004 Dec; 13(12):841-53.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.